Hiroyuki Ueno
Directeur/Membre du Conseil chez Alphanavi Pharma KK
Profil
Hiroyuki Ueno is currently a Director at Alphanavi Pharma KK and an Executive Manager at Kyoto University Innovation Capital Co., Ltd.
He previously worked as an Outside Director at Chordia Therapeutics, Inc.
Postes actifs de Hiroyuki Ueno
| Sociétés | Poste | Début |
|---|---|---|
Kyoto University Innovation Capital Co., Ltd.
 Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Private Equity Investor | 01/10/2020 |
Alphanavi Pharma KK
 Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Alphanavi Pharma KK is a pharmaceutical company based in Kyoto, Japan that focuses on developing new treatments for chronic pain. The Japanese company's goal is to alleviate discomfort and bring smiles back to patients and their families. The company was founded in 2019 by Yoshihiro Koyamada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Hiroyuki Ueno
| Sociétés | Poste | Fin |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHORDIA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kyoto University Innovation Capital Co., Ltd.
Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Finance |
Alphanavi Pharma KK
Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Alphanavi Pharma KK is a pharmaceutical company based in Kyoto, Japan that focuses on developing new treatments for chronic pain. The Japanese company's goal is to alleviate discomfort and bring smiles back to patients and their families. The company was founded in 2019 by Yoshihiro Koyamada. | Health Technology |
